Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction
Sponsor: Pharmicell Co., Ltd.
Summary
This phase II clinical trial with safety follow-up is designed to evaluate the efficacy and safety of Cellgram-ED (autologous bone marrow-derived mesenchymal stem cells) administered via intracavernous injection in patients with erectile dysfunction after radical prostatectomy.
Official title: A Safety Follow-up Study of a Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Cellgram-ED (Autologous Bone Marrow-Derived Mesenchymal Stem Cells) in Patients With Post-Radical Prostatectomy Erectile Dysfunction
Key Details
Gender
MALE
Age Range
19 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
32
Start Date
2024-12-26
Completion Date
2030-01-10
Last Updated
2026-02-24
Healthy Volunteers
No
Conditions
Locations (4)
Asan medical center
Seoul, South Korea
Ewha womans university medical center
Seoul, South Korea
Samsung medical center
Seoul, South Korea
Seoul ST. Mary's hospital
Seoul, South Korea